Which option best describes data retention in trials?

• A. Delete data immediately after collection.
• B. Release all data publicly without safeguards.
• C. Retain data only for marketing purposes.
• D. Retain data for reference and potential audits.

Answer: (D)

Data retention in trials refers to keeping trial data for a period that allows verification of results, enables regulatory inspections, and supports ongoing safety monitoring. This practice ensures the study can be reviewed, audited, or re-analyzed if needed, and it helps protect the integrity of the data and the rights of participants.

The option describing retention for reference and potential audits is the best match because it directly supports those aims: having data available to verify findings, respond to inquiries from regulators, and conduct possible future analyses, all while following approved retention periods and security measures. Data should be stored securely, with access controls and, where appropriate, de-identification to protect participant privacy. The specific retention period is defined in the trial protocol and applicable regulations, and data should be preserved in a manner that preserves its integrity over time.

Deleting data immediately would hinder verification and regulatory review. Releasing all data publicly without safeguards would violate participant privacy and confidentiality. Retaining data only for marketing purposes ignores the trial’s primary purpose, undermines data integrity, and fails to meet regulatory and ethical standards.